High-potency cannabis can damage brain: Study

The corpus callosum is particularly rich in cannabinoid receptors, on which the THC content of cannabis acts

High-potency cannabis can damage brain: Study
Press Trust of India London
Last Updated : Nov 27 2015 | 2:34 PM IST
Smoking high potency 'skunk-like' cannabis can damage a crucial part of the brain responsible for communication between the two brain hemispheres, a new study has found.

Today's high potency 'skunk-like' products have been shown to contain higher proportions of Tetrahydrocannabinol (THC) than they did around a decade ago.

In experimental studies THC has been shown to induce psychotic symptoms and 'skunk-like' products high in THC are now thought to be the most commonly used form of cannabis in the UK, researchers said.

Also Read

Researchers examined the corpus callosum, the largest white matter structure in the brain, which is responsible for communication between the left and right hemispheres.

White matter consists of large bundles of nerve cell projections (axons), which connect different regions of the brain, enabling communication between them.

The corpus callosum is particularly rich in cannabinoid receptors, on which the THC content of cannabis acts.

The study found that frequent use of high potency cannabis was linked to significantly higher mean-diffusivity (MD), a marker of damage in white matter structure.

"We found that frequent use of high potency cannabis significantly affects the structure of white matter fibres in the brain, whether you have psychosis or not. This reflects a sliding scale where the more cannabis you smoke and the higher the potency, the worse the damage will be," Paola Dazzan from King's college London and senior researcher on the study said.

Diffusion Tensor Imaging (DTI), a Magnetic Resonance Imaging (MRI) technique, was used to examine white matter in the brains of 56 patients who had reported a first episode of psychosis, as well as 43 healthy participants.

"This white matter damage was significantly greater among heavy users of high potency cannabis than in occasional or low potency users, and was also independent of the presence of a psychotic disorder," Tiago Reis Marques, senior researcher at King's college said.

The study was published in the journal Psychological Medicine.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 27 2015 | 2:25 PM IST

Next Story